Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Cefaclor
Drug ID BADD_D00378
Description Semisynthetic, broad-spectrum antibiotic derivative of cephalexin.
Indications and Usage For the treatment of certain infections caused by bacteria such as pneumonia and ear, lung, skin, throat, and urinary tract infections.
Marketing Status Prescription; Discontinued
ATC Code J01DC04
DrugBank ID DB00833
KEGG ID D00256
MeSH ID D002433
PubChem ID 51039
TTD Drug ID D0PW7C
NDC Product Code 0093-1087; 0143-9985; 61442-172; 63629-1007; 23594-375; 61442-171; 23594-250; 0143-9986; 50090-1602; 23594-125
Synonyms Cefaclor | Cefaclor Anhydrous | Keclor | 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-chloro-8-oxo-, (6R-(6alpha,7beta(R*)))- | S-6472 | S 6472 | S6472 | Ceclor | Cefaclor Monohydrate | Lilly 99638
Chemical Information
Molecular Formula C15H14ClN3O4S
CAS Registry Number 53994-73-3
SMILES C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Serum sickness-like reaction10.01.03.005; 08.01.03.003--Not Available
Shock24.06.02.002--Not Available
Sinusitis11.01.13.005; 22.07.03.007--
Skin reaction23.03.03.013; 10.01.03.019--Not Available
Somnolence19.02.05.003; 17.02.04.006--
Stevens-Johnson syndrome12.03.01.014; 11.07.01.005; 10.01.03.020; 23.03.01.007--
Superinfection11.01.08.009--Not Available
Syncope24.06.02.012; 17.02.04.008; 02.01.02.008--
Syndactyly15.11.07.015; 03.11.07.0150.000213%Not Available
Tension19.06.02.005--Not Available
Thrombocytopenia01.08.01.002--Not Available
Thrombocytosis01.08.02.001--Not Available
Toxic epidermal necrolysis23.03.01.008; 12.03.01.015; 11.07.01.006; 10.01.01.006--
Tremor17.01.06.002--
Urethral disorder20.07.01.002--Not Available
Urinary tract disorder20.08.01.001--Not Available
Urinary tract infection20.08.02.001; 11.01.14.0040.000639%
Urine glucose false positive13.02.02.006--Not Available
Urticaria23.04.02.001; 10.01.06.0010.000213%
Vaginal discharge21.08.02.002--
Vaginal infection21.14.02.002; 11.01.10.002--
Vaginal inflammation21.14.02.001--
Vasodilatation24.03.02.003; 23.06.05.006--Not Available
Vertigo04.04.01.003; 17.02.12.002--
Vomiting07.01.07.0030.000213%
Vulvovaginal candidiasis21.14.02.003; 11.03.03.005--Not Available
Tubulointerstitial nephritis20.05.02.002--Not Available
Lymphatic disorder01.09.01.003--Not Available
Musculoskeletal discomfort15.03.04.001--Not Available
Foetal death18.01.02.003; 08.04.01.0110.000639%
The 5th Page    First    Pre   5 6    Next   Last    Total 6 Pages